Vaccination of sarcoid-bearing donkeys with chimeric virus-like particles of bovine papillomavirus type 1

Journal of General Virology

Volumn 89, Issue 1, 2008, Pages 148-157

  Ashrafi, G H ^a,d   Piuko, K ^b   Burden, F ^c   Yuan, Z ^a   Gault, E A ^a   Muller M ^b   Trawford, A ^c   Reid, S W J ^a   Nasir, L ^a   Campo, M S ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c THE DONKEY SANCTUARY   (United Kingdom)

^d UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROTEIN E7; PROTEIN L1; TUMOR VACCINE; UNCLASSIFIED DRUG; VIROTHERAPY AGENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHIMERA; CLINICAL EXAMINATION; CLINICAL PROTOCOL; CONTROLLED STUDY; DONKEY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMORAL IMMUNITY; MALE; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; SARCOIDOSIS; TUMOR CELL; TUMOR REGRESSION; VACCINATION; VIRUS LIKE AGENT; VIRUS NEUTRALIZATION;

ANIMAL DISEASES; ANIMALS; BOVINE PAPILLOMAVIRUS 1; CHIMERA; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EQUIDAE; FEMALE; MALE; NEUTRALIZATION TESTS; SARCOIDOSIS; VIRAL LOAD; VIRAL VACCINES;

ANIMALIA; BOVINE PAPILLOMAVIRUS TYPE 1; BOVINE PARVOVIRUS; EQUIDAE;

EID: 38349049458     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.83267-0     Document Type: Article

References (42)

1. Araibi, E. H., Marchetti, B., Ashrafi, G. H. & Campo, M. S. (2004). Down-regulation of MHC class I in bovine papillomas. J Gen Virol 85, 2809-2814.
2. Ashrafi, G. H., Tsirimonaki, E., Marchetti, B., O'Brien, P. M., Sibbet, G. J., Andrew, L. & Campo, M. S. (2002). Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene 21, 248-259.
3. Campo, M. S. (2006). Bovine papillomavirus: old system, new lessons? In Papillomavirus Research: from Natural History to Vaccines and Beyond, pp. 373-387. Edited by M. S. Campo. Norfolk, UK: Caister Academic Press.
4. Campo, M. S., Grindlay, G. J., O'Neil, B. W., Chandrachud, L. M., McGarvie, G. M. & Jarrett, W. F. (1993). Prophylactic and therapeutic vaccination against a mucosal papillomavirus. J Gen Virol 74, 945-953.
5. Campo, M. S., O'Neil, B. W., Grindlay, G. J., Curtis, F., Knowles, G. & Chandrachud, L. (1997). A peptide encoding a B-cell epitope from the N-terminus of the capsid protein L2 of bovine papillomavirus-4 prevents disease. Virology 234, 261-266.
6. Carr, E. A., Théon, A. P., Madewell, B. R., Hitchcock, M. E., Schlegel, R. & Schiller, J. T. (2001). Expression of a transforming gene (E5) of bovine papillomavirus in sarcoids obtained from horses. Am J Vet Res 62, 1212-12l7.
7. Chambers, G., Ellsmore, V. A., O'Brien, P. M., Reid, S. W. J., Love, S., Campo, M. S. & Nasir, L. (2003). Sequence variants of bovine papillomavirus E5 detected in equine sarcoids. Virus Res 96, 141-145.
8. Chandrachud, L. M., O'Neil, B. W., Jarrett, W. F., Grindlay, G. J., McGarvie, G. M. & Campo, M. S. (1994). Humoral immune response to the E7 protein of bovine papillomavirus type 4 and identification of B-cell epitopes. Virology 200, 98-104.
9. Chandrachud, L. M., Grindlay, G. J., McGarvie, G. M., O'Neil, B. W., Wagner, E. R., Jarrett, W. F. & Campo, M. S. (1995). Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4. Virology 211, 204-208.
10. Coleman, N., Birley, H. D., Renton, A. M., Hanna, N. F., Ryait, B. K., Byrne, M., Taylor-Robinson, D. & Stanley, M. A. (1994). Immunological events in regressing genital warts. Am J Clin Pathol 102, 768-774.
11. Cotzer, J. A. W. & Guthrie, A. J. (2004). African horse sickness. In Infectious Diseases of Livestock, pp. 1231-1246. Edited by J. A. W. Coetzer & R. C. Tustin. Oxford: Oxford University Press.
12. European Medicines Agency (2006). www.emea.europa.eu/human-docs/ Humans/EPAR/gardasil/gardasil.htm
13. Frazer, I. H. (1996). Immunology of papillomavirus infection. Curr Opin Immunol 8, 484-491.
14. Giroglou, T., Florin,, L., Schafer, F., Streeck, R. E. & Sapp, M. (2001). Human papillomavirus infection requires cell surface heparan sulfate. J Virol 75, 1565-1570.
15. Gorman, N. T. (1985). Equine sarcoid: time for optimism. Equine Vet J 17, 412-414.
16. Govan, V. A. (2005). Strategies for human papillomavirus therapeutic vaccines and other therapies based on the E6 and E7 oncogenes. Ann N Y Acad Sci 1056, 328-343.
17. Howell, P. G., Guthrie, A. J. & Coetzer, J. A. W. (2004). Equine encephalosis. In Infectious Diseases of Livestock, pp. 1247-1251. Edited by J. A. W. Coetzer & R. C. Tustin. Oxford: Oxford University Press.
18. Jackson, C. (1936). The incidence and pathology of tumours of domesticated animals in South Africa, pp. 378-385. Pretoria, South Africa: Union of South Africa, Department of Agriculture.
19. Jarrett, W. F., Smith, K. T., O'Neil, B. W., Gaukroger, J. M., Chandrachud, L. M., Grindlay, G. J., McGarvie, G. M. & Campo, M. S. (1991). Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteins. Virology 184, 33-42.
20. Kirnbauer, R., Chandrachud, L. M., O'Neil, B. W., Wagner, E. R., Grindlay, G. J., Armstrong, A., McGarvie, G. M., Schiller, J. T., Lowy, D. R. & Campo, M. S. (1996). Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. Virology 219, 37-44.
21. Knottenbelt, D. C. (2005). A suggested clinical classification for the equine sarcoid. Clin Tech Equine Pract 4, 278-295.
22. Knowles, G., O'Neil, B. W. & Campo, M. S. (1996). Phenotypical characterization of lymphocytes infiltrating regressing papillomas. J Virol 70, 8451-8458.
23. Lancaster, W. D., Theillen, G. H. & Olson, C. (1979). Hybridisation of bovine papillomavirus type 1 and type 2 DNA to DNA from virus-induced hamster tumours and naturally occurring equine tumours. Intervirology 11, 227-233.
24. Marchetti, B., Ashrafi, G. H., Tsirimonaki, E., O'Brien, P. M. & Campo, M. S. (2002). The papillomavirus oncoprotein E5 retains the major histocompatibility class I in the Golgi apparatus and prevents its transport to the cell surface. Oncogene 21, 7808-7816.
25. Marchetti, B., Ashrafi, G. H., Doman, E. S., Araibi, E. H., Ellis, S. A. & Campo, M. S. (2006). The E5 protein of BPV-4 interacts with the heavy chain of MHC class I and irreversibly retains the MHC complex in the Golgi apparatus. Oncogene 27, 2254-2263.
26. Marti, E., Lazary, S., Antczak, D. F. & Gerber, H. (1993). Report of the first international workshop on equine sarcoid. Equine Vet J 25, 397-407.
27. Mattil-Fritz, S., Scharner, D., Piuko, K., Thönes, N., Gissmann, L., Müller, H. & Müller, M. (2008). Immunotherapy of equine sarcoid: dose escalation trial for the use of chimeric papillomavirus-like particles. J Gen Virol 89, 138-147.
28. Mejia, A. F., Culp, T. D., Cladel, N. M., Balogh, K. K., Budgeon, L. R., Buck, C. B. & Christensen, N. D. (2006). Preclinical model to test human papillomavirus virus (HPV) capsid vaccines in vivo using infectious HPV/cottontail rabbit papillomavirus chimeric papilloma-virus particles. J Virol 80, 12393-12397.
29. Müller, M., Zhou, J., Reed, T. D., Rittmuller, C., Burger, A., Gabelsberger, J., Braspenning, J. & Gissmann, L. (1997). Chimeric papillomavirus-like particles. Virology 234, 93-111.
30. Nasir, L. & Reid, S. W. J. (1999). Bovine papillomaviral gene expression in equine sarcoid tumours. Virus Res 61, 171-175.
31. Nasir, L. & Reid, S. W. J. (2006). Bovine papillomaviruses and equine sarcoids. In Papillomavirus Research: from Natural History to Vaccines and Beyond, pp. 389-397. Edited by M. S. Campo. Norfolk, UK: Caister Academic Press.
32. Newton, J. R. & Mumford, J. A. (2004). Equine influenza. In Infectious Diseases of Livestock, pp. 766-774. Edited by J. A. W. Coetzer & R. C. Tustin. Oxford: Oxford University Press.
33. Okabayashi, M., Angell, M. G., Christensen, N. D. & Kreider, J. W. (1991). Morphometric analysis and identification of infiltrating leucocytes in regressing and progressing Shope rabbit papillomas. Int J Cancer 49, 919-923.
34. Pascoe, R. R. & Summers, P. M. (1981). Clinical survey of tumours and tumour-like lesions in horses in south east Queensland. Equine Vet J 13, 235-239.
35. Ragland, W. H., Keown, G. H. & Spencer, G. R. (1970). Equine sarcoid. Equine Vet J 12, 2-11.
36. Reid, S. W., Gettinby, G., Fowler, J. N. & Ikin, P. (1994). Epidemiological observations on sarcoids in a population of donkeys (Equus asinus). Vet Rec 134, 207-211.
37. Roberts, W. D. (1970). Experimental treatment of equine sarcoid. Vet Med Small Anim Clin 65, 67-73.
38. Roden, R. B. S. & Viscidi, R. P. (2006). Papillomavirus-like particles and their applications in molecular virology, human serology and vaccines. In Papillomavirus Research: from Natural History to Vaccine and Beyond, pp. 279-310. Edited by M. S. Campo. Norfolk, UK: Caister Academic Press.
39. Saslow, D., Castle, P. E., Cox, J. T., Davey, D. D., Einstein, M. H., Ferris, D. G., Goldie, S. J., Harper, D. M., Kinney, W. & other authors (2007). American Cancer Society guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin 57, 7-28.
40. Wu, T. C. (2007). Therapeutic human papillomavirus DNA vaccination strategies to control cervical cancer. Eur J Immunol 37, 310-314.
41. Yuan, Z., Gallagher, A., Gault, E. A., Campo, M. S. & Nasir, L. (2006). Bovine papillomavirus infection in equine sarcoids and in bovine bladder cancers. Vet J 174, 599-604.
42. Yuan, Z., Philbey, A. W., Gault, E. A., Campo, M. S. & Nasir, L. (2007). Detection of bovine papillomavirus type 1 genomes and viral gene expression in equine inflammatory skin conditions. Virus Res 124, 245-249.